Pipeline
Partnered and in-house drug development programs
In our partnered programs, we are working with pharma partners to stabilize novel drug targets and enable drug development against targets. For our internal pipeline, we are striving to develop drugs against drug targets that have thus far remained inaccessible.
Abbreviations: A1R, Adenosine A1 receptor; CXCR2, C-X-C chemokine receptor type 2; CXCR4, C-X-C chemokine receptor type 4; CXCR7, C-X-C chemokine receptor type 7; EGFR, Epidermal growth factor receptor; GPCR, G Protein-Coupled Receptor; GPNMB, Glycoprotein Nmb; GPR75, G-protein coupled receptor 75; MCT1, Monocarboxylate transporter 1; Pannexin 1; SLC, Solute Carrier; TCR/CD3, T-cell receptor/cluster of differentiation 3; TRPV3, Transient receptor potential vanilloid-3